Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Malignant H1299 tumour cells preferentially internalize iron-bound inositol hexakisphosphate.

Helmis C, Blechner C, Lin H, Schweizer M, Mayr GW, Nielsen P, Windhorst S.

Biosci Rep. 2013 Oct 22;33(5). pii: e00075. doi: 10.1042/BSR20130079.

2.

Siderophore activity of myo-inositol hexakisphosphate in Pseudomonas aeruginosa.

Smith AW, Poyner DR, Hughes HK, Lambert PA.

J Bacteriol. 1994 Jun;176(12):3455-9.

3.

Tumour cells can employ extracellular Ins(1,2,3,4,5,6)P(6) and multiple inositol-polyphosphate phosphatase 1 (MINPP1) dephosphorylation to improve their proliferation.

Windhorst S, Lin H, Blechner C, Fanick W, Brandt L, Brehm MA, Mayr GW.

Biochem J. 2013 Feb 15;450(1):115-25. doi: 10.1042/BJ20121524.

PMID:
23186306
4.

The intracellular distribution of inositol polyphosphates in HL60 promyeloid cells.

Stuart JA, Anderson KL, French PJ, Kirk CJ, Michell RH.

Biochem J. 1994 Oct 15;303 ( Pt 2):517-25.

5.

Inhibition of iron-catalysed hydroxyl radical formation by inositol polyphosphates: a possible physiological function for myo-inositol hexakisphosphate.

Hawkins PT, Poyner DR, Jackson TR, Letcher AJ, Lander DA, Irvine RF.

Biochem J. 1993 Sep 15;294 ( Pt 3):929-34.

6.

Characterization of inositol hexakisphosphate (InsP6)-mediated priming in human neutrophils: lack of extracellular [3H]-InsP6 receptors.

Kitchen E, Condliffe AM, Rossi AG, Haslett C, Chilvers ER.

Br J Pharmacol. 1996 Mar;117(5):979-85.

7.

Intracellular and extracellular myo-inositol hexakisphosphate (InsP6), from rats to humans.

Grases F, Costa-Bauza A, Prieto RM.

Anticancer Res. 2005 May-Jun;25(3c):2593-7.

8.

Inositol hexakisphosphate binding sites in rat heart and brain.

Rowley KG, Gundlach AL, Cincotta M, Louis WJ.

Br J Pharmacol. 1996 Aug;118(7):1615-20.

9.
10.

Cytotoxic effect of inositol hexaphosphate and its Ni(II) complex on human acute leukemia Jurkat T cells.

de Lima EM, Kanunfre CC, de Andrade LF, Granato D, Rosso ND.

Toxicol In Vitro. 2015 Dec;29(8):2081-8. doi: 10.1016/j.tiv.2015.08.018. Epub 2015 Aug 31.

11.

Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid).

Sakamoto K, Venkatraman G, Shamsuddin AM.

Carcinogenesis. 1993 Sep;14(9):1815-9.

PMID:
7691427
12.
13.
14.
15.

Visualization of inositol phosphate-dependent mobility of Ku: depletion of the DNA-PK cofactor InsP6 inhibits Ku mobility.

Byrum J, Jordan S, Safrany ST, Rodgers W.

Nucleic Acids Res. 2004 May 18;32(9):2776-84. Print 2004.

16.

Inositol hexakisphosphate-mediated regulation of glutamate receptors in rat brain sections.

Valastro B, Girard M, Gagné J, Martin F, Parent AT, Baudry M, Massicotte G.

Hippocampus. 2001;11(6):673-82.

PMID:
11811661
17.

Inositol hexakisphosphate (phytic acid) enhances Ca2+ influx and D-[3H]aspartate release in cultured cerebellar neurons.

Nicoletti F, Bruno V, Fiore L, Cavallaro S, Canonico PL.

J Neurochem. 1989 Oct;53(4):1026-30.

PMID:
2769253
18.

Inositol hexakisphosphate and beta-cell stimulus-secretion coupling.

Barker CJ, Berggren PO.

Anticancer Res. 1999 Sep-Oct;19(5A):3737-41. Review.

PMID:
10625950
19.
20.

Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption.

Grases F, Isern B, Perelló J, Sanchis P, Prieto RM.

Front Biosci. 2005 Jan 1;10:799-802. Print 2005 Jan 1.

PMID:
15569619

Supplemental Content

Support Center